Neurologic uses of botulinum neurotoxin type A
John P Ney, Kevin R JosephMadigan Army Medical Center, Neurology Service, Tacoma, WA, USAAbstract: This article reviews the current and most neurologic uses of botulinum neurotoxin type A (BoNT-A), beginning with relevant historical data, neurochemical mechanism at the neuromuscular junction. Curren...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bd19972e45e94d59811dee16cc73c4b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bd19972e45e94d59811dee16cc73c4b8 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bd19972e45e94d59811dee16cc73c4b82021-12-02T00:56:52ZNeurologic uses of botulinum neurotoxin type A1176-63281178-2021https://doaj.org/article/bd19972e45e94d59811dee16cc73c4b82007-01-01T00:00:00Zhttp://www.dovepress.com/neurologic-uses-of-botulinum-neurotoxin-type-a-a957https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021John P Ney, Kevin R JosephMadigan Army Medical Center, Neurology Service, Tacoma, WA, USAAbstract: This article reviews the current and most neurologic uses of botulinum neurotoxin type A (BoNT-A), beginning with relevant historical data, neurochemical mechanism at the neuromuscular junction. Current commercial preparations of BoNT-A are reviewed, as are immunologic issues relating to secondary failure of BoNT-A therapy. Clinical uses are summarized with an emphasis on controlled clinical trials (as appropriate), including facial movement disorders, focal neck and limb dystonias, spasticity, hypersecretory syndromes, and pain.Keywords: botulinum neurotoxins, BOTOX®, Dysport®, chemodenervation John P NeyKevin R JosephDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2007, Iss Issue 6, Pp 785-798 (2007) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 John P Ney Kevin R Joseph Neurologic uses of botulinum neurotoxin type A |
description |
John P Ney, Kevin R JosephMadigan Army Medical Center, Neurology Service, Tacoma, WA, USAAbstract: This article reviews the current and most neurologic uses of botulinum neurotoxin type A (BoNT-A), beginning with relevant historical data, neurochemical mechanism at the neuromuscular junction. Current commercial preparations of BoNT-A are reviewed, as are immunologic issues relating to secondary failure of BoNT-A therapy. Clinical uses are summarized with an emphasis on controlled clinical trials (as appropriate), including facial movement disorders, focal neck and limb dystonias, spasticity, hypersecretory syndromes, and pain.Keywords: botulinum neurotoxins, BOTOX®, Dysport®, chemodenervation |
format |
article |
author |
John P Ney Kevin R Joseph |
author_facet |
John P Ney Kevin R Joseph |
author_sort |
John P Ney |
title |
Neurologic uses of botulinum neurotoxin type A |
title_short |
Neurologic uses of botulinum neurotoxin type A |
title_full |
Neurologic uses of botulinum neurotoxin type A |
title_fullStr |
Neurologic uses of botulinum neurotoxin type A |
title_full_unstemmed |
Neurologic uses of botulinum neurotoxin type A |
title_sort |
neurologic uses of botulinum neurotoxin type a |
publisher |
Dove Medical Press |
publishDate |
2007 |
url |
https://doaj.org/article/bd19972e45e94d59811dee16cc73c4b8 |
work_keys_str_mv |
AT johnpney neurologicusesofbotulinumneurotoxintypea AT kevinrjoseph neurologicusesofbotulinumneurotoxintypea |
_version_ |
1718403406194802688 |